Former positions: APAF CEO; Director (Biomarker Discovery), LumiCyte, Fremont, CA, USA; Co-Director & Scientific Director, Gynecological Cancer Research Centre, Royal Women's Hospital, Melbourne; Associate Professor, Biological Sciences, University of Wollongong; Research Fellow, John Curtin School of Medical Research, ANU; Post-doctoral Fellow, Biochemistry, Monash University.
In 1995 when receiving his PhD degree in Biophysics from Johns Hopkins University, he has determined the crystal structure of several critical apoptotic proteins, including apaf-1, DIAP1, and the BIR3 domain of XIAP.